Replimune (REPL) Free Cash Flow (2017 - 2025)
Replimune has reported Free Cash Flow over the past 9 years, most recently at -$66.1 million for Q4 2025.
- Quarterly results put Free Cash Flow at -$66.1 million for Q4 2025, down 39.82% from a year ago — trailing twelve months through Dec 2025 was -$288.5 million (down 51.43% YoY), and the annual figure for FY2025 was -$198.9 million, down 4.09%.
- Free Cash Flow reached -$66.1 million in Q4 2025 per REPL's latest filing, up from -$84.6 million in the prior quarter.
- Across five years, Free Cash Flow topped out at -$16.1 million in Q1 2021 and bottomed at -$84.6 million in Q3 2025.
- Median Free Cash Flow over the past 5 years was -$42.9 million (2023), compared with a mean of -$42.4 million.
- The largest annual shift saw Free Cash Flow increased 10.26% in 2024 before it crashed 107.87% in 2025.
- Over 5 years, Free Cash Flow stood at -$18.8 million in 2021, then crashed by 44.28% to -$27.1 million in 2022, then crashed by 65.96% to -$45.0 million in 2023, then decreased by 4.93% to -$47.3 million in 2024, then tumbled by 39.82% to -$66.1 million in 2025.
- Business Quant data shows Free Cash Flow for REPL at -$66.1 million in Q4 2025, -$84.6 million in Q3 2025, and -$77.7 million in Q2 2025.